×

Therapeutic inhibitor of vascular smooth muscle cells

  • US 5,811,447 A
  • Filed: 05/25/1995
  • Issued: 09/22/1998
  • Est. Priority Date: 01/28/1993
  • Status: Expired due to Term
First Claim
Patent Images

1. A method for biologically stenting a mammalian blood vessel, which method comprises:

  • administering to the blood vessel of a mammal cytochalasin B or a cytochalasin that is a functional analog of cytochalasin B in an amount and for a period of time effective to inhibit the contraction of vascular smooth muscle cells while not eliminating their ability to secrete extracellular matrix.

View all claims
  • 4 Assignments
Timeline View
Assignment View
    ×
    ×